Poster Awards, worth €250 each, are awarded to the eight best posters (four clinical and four basic) on display at the annual European Congress of Endocrinology (ECE).
There is no application process. The top ten clinical and top ten basic posters are reviewed by members of the ECE Programme Organising Committee during the congress.
- The applicant will be the presenting author of the poster during ECE.
- The applicant must be a current member of ESE and be within 10 years post-PhD or MD.
The eight awarded posters, 4 clinical and 4 basic, are selected from the top 10 clinical and 10 basic poster abstracts which attained the best ratings during the abstract evaluation process, based on the scientific content and on the quality of the poster presentation. The prizes are bestowed by the Programme Organising Committee to the presenting author of the eight selected posters.
2022 Poster Award Winners – Clinical
- Poster P396, awarded to Alessandro Maria Berton, Italy: Precision medicine: new perspectives for the treatment of GH-secreting tumors - The Miss Study
- Poster RC12.3, awarded to Joeri Walravens, Belgium: Binding Affinity Affecting SHBG SNPs Do Not Majorly Affect Calculated Estimates of Free Testosterone
- Poster RC12.4, awarded to Georgios Papadakis, Switzerland: Unraveling the link between metabolism and reproduction in obese men
- Poster RC12.7, awarded to Giulia Rodari, Italy: Pubertal induction in girls with hypogonadism: insight into estrogen replacement therapy outcomes and optimization of progesterone introduction
2022 Poster Award Winners – Basic/Translational
- Poster P59, awarded to Hamza Benderradji, France: Impaired glucose homeostasis in a tau knock-in mouse model
- Poster P123, awarded to Gloria Elena Silva Román, Mexico: The transcriptomic and methylomic landscape of POU1F1 pituitary tumors
- Poster P324, awarded to Manuel D. Gahete, Spain: Characterization of the somatostatin and ghrelin hormonal systems revealed their potential therapeutic role in chronic liver disease
- Poster RC2.1, awarded to Chris Smith, United Kingdom: A rapid genetic diagnosis for >80% individuals with non-CAH Primary Adrenal Insufficiency is achievable by candidate gene sequencing combined with WES